Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07211867 · ClinicalTrials.gov registry record · NA
A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder
A NA study of Substance Use Disorder, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT07211867 is a NA study of Substance Use Disorder that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 152 participants, below the 814-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07211867, a NA study of Substance Use Disorder, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
Digital interventions have the potential to support healthier behaviors among pregnant and postpartum women (PPW) with substance use disorders (SUDs) and may also provide a promising method for reducing their self-stigma. Enhearten is a digital intervention designed to foster adherence to medications for addiction treatment (MAT) while considering the unique needs of PPW, but its effects on self-stigma, treatment retention, and SUD outcomes have not been rigorously tested. The investigators will conduct an individual-level multicenter randomized controlled trial to test the feasibility, acceptability, and efficacy of Enhearten on reducing self-stigma and on improving SUD treatment and recovery outcomes with a stigma-focused ecological momentary intervention (EMI) designed to: 1) screen for feelings of stigma and 2) counteract these vulnerabilities among PPW with SUD via just-in-time interventions.
Conditions Studied
Interventions
- BEHAVIORAL Waitlist Control Group
- BEHAVIORAL Enhearten with EMI
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07211867
The ClinicalTrials.gov registry entry for NCT07211867 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 814-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (81% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Substance Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Waitlist Control Group is the first listed.
NCT07211867 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07211867 about?
NCT07211867 is a clinical study titled "A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder". Digital interventions have the potential to support healthier behaviors among pregnant and postpartum women (PPW) with substance use disorders (SUDs) and may also provide a promising method for reducing their self-stigma. Enhearten is a digital intervention designed to foster adherence to medication...
What is the current status of trial NCT07211867?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2025-11-24. Estimated completion is 2027-05.
What conditions does trial NCT07211867 study?
This clinical trial studies the following conditions: Substance Use Disorder.
What interventions are being tested in trial NCT07211867?
The interventions under investigation include: Waitlist Control Group (BEHAVIORAL), Enhearten with EMI (BEHAVIORAL).
Who is sponsoring clinical trial NCT07211867?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07211867 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
A Type I Hybrid Effectiveness-Implementation Trial of MIO
RECRUITING · NA
-
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
RECRUITING · NA
-
Personalized Approach to Healthy Use and Recovery (PATH) Trial
RECRUITING · NA
-
Defining Neurobiological Links Between Substance Use and Mental Illness
RECRUITING · NA
-
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.